SCHEMBL456883

SCHEMBL456883

CCc1[c]c(OC)ccc1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPK1 P28482 1/20 0.31
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11503610 0.83 ALOX5 (0.32) SMN1; SMN2PTGS2
SCHEMBL7312733 0.81 SMN1; SMN2 (0.32) SMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL18706209 0.81 TAAR1 (0.32) SMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7772526 0.81 NQO1 (0.36) ALDH1A1
SCHEMBL18705840 0.81 SMN1; SMN2 (0.32) SMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL1552343 0.80 ALOX5 (0.37) SMN1; SMN2PTGS2
SCHEMBL11503560 0.79 ADRA2A (0.30)
SCHEMBL18705611 0.79 HTR7 (0.36) SMN1; SMN2ALDH1A1
SCHEMBL57641 0.78 ALDH1A1 (0.41) SMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL177278 0.78 GABRA1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1219752-C Process for preparing substituted hydrazide by using carboxylic acid DOW AGROSCIENCES LLC (US) 2005-09-21 CN claimed
EP-0986560-B1 PYRROLO 2,1,5-CD]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES KAROBIO AB (SE) 2004-03-24 EP claimed
CN-1248576-A Process for preparing substituted hydrazide by using carboxylic acid ROHM & HAAS (US) 2000-03-29 CN claimed
EP-2841429-B1 TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2020-10-21 EP disclosed
US-10077254-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-09-18 US disclosed
EP-3045450-B1 INTERMEDIATE COMPOUNDS IN PROCESSES FOR PRODUCING PYRIDAZINONE COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2018-02-07 EP disclosed
EP-3059233-B1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME SUMITOMO CHEMICAL CO (JP) 2017-12-20 EP disclosed
CN-104245689-B Terazololine-one compound and its purposes as insecticide 住友化学株式会社 2017-06-06 CN disclosed
US-9565856-B2 Tetrazolinone compounds and its use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-14 US disclosed
US-20160272622-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-22 US disclosed
CN-104326952-B Prepare method and its intermediate of pyridazinone compound 住友化学株式会社 2016-08-24 CN disclosed
CN-100564383-C Organosilicon compound and manufacture method thereof SUMITOMO CHEMICAL CO (JP) 2009-12-02 CN disclosed
CN-1930174-A Organosilicon compound and method for producing same SUMITOMO CHEMICAL CO (JP) 2007-03-14 CN disclosed
CN-1219752-C Process for preparing substituted hydrazide by using carboxylic acid DOW AGROSCIENCES LLC (US) 2005-09-21 CN disclosed
CN-1114602-C Ketone derivatives and medicinal use thereof TORAY INDUSTRIES (JP) 2003-07-16 CN disclosed
EP-1115700-A1 OPTICALLY ACTIVE SUBSTITUTED N-ARYL-O-ARYLOXYALKYL-CARBAMATES BAYER AG (DE) 2001-07-18 EP disclosed
WO-2000017157-A1 OPTICALLY ACTIVE SUBSTITUTED N-ARYL-O-ARYLOXYALKYL-CARBAMATES BAYER AKTIENGESELLSCHAFT (DE) 2000-03-30 WO disclosed
CN-1248576-A Process for preparing substituted hydrazide by using carboxylic acid ROHM & HAAS (US) 2000-03-29 CN disclosed
CN-1242771-A Ketone derivatives and medicinal use thereof TORAY INDUSTRIES (JP) 2000-01-26 CN disclosed
US-4169106-A Antiarrhythmic N,N'-bis(phenylcarbamoylalkyl)amidines COOPER LABORATORIES, INC. (US) 1979-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077254-B2 Tetrazolinone compound and use thereof MT-CO1, UQCRB, MT-CO2 SMN1; SMN2 1886/4885KDM4E 2469/4885ALDH1A1 1465/4885
US-20160272622-A1 TETRAZOLINONE COMPOUND AND USE THEREOF MT-CO1, UQCRB, MT-CO2 SMN1; SMN2 1886/4885KDM4E 2469/4885ALDH1A1 1465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.